The utility of proliferation markers such as Ki67 cannot be underestimated in the grading of thyroid carcinoma, which has been shown to be a predictor of clinical behavior in both follicular and C-cell-derived neoplasms (1, 2, 7). This evidence concerns the gene MKI67 and thyroid gland carcinoma.